Where do Eli Lilly's ratios come from?

Every ratio is computed from Eli Lilly's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Eli Lilly LLY Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	331.5%+1.1pp	330.4%+1.7pp	328.7%+2.1pp	326.6%+1.9pp	324.7%+1.5pp
Net margin	123.5%+12.3pp	111.2%+8.2pp	103.1%+10.5pp	92.6%+7.0pp	85.5%+5.6pp
Returns
Return on equity	392.3%+29.9pp	362.4%+16.6pp	345.8%+31.1pp	314.7%+27.1pp	287.7%+26.6pp
Return on invested capital	147%+16.6pp	130.3%+11.8pp	118.5%+13.8pp	104.7%+7.2pp	97.4%+5.9pp
Efficiency
Asset turnover	2.6×+0.1×	2.6×+0.1×	2.5×0.0×	2.5×0.0×	2.5×0.0×
Liquidity
Current ratio	5.9×+0.1×	5.8×+0.4×	5.4×+0.3×	5.1×+0.2×	4.9×0.0×
Leverage
Debt-to-equity	7×-1.1×	8×-0.8×	8.9×-0.4×	9.3×+0.1×	9.2×+0.4×
Net debt / EBITDA	5.7×-1.1×	6.9×-0.9×	7.8×-1.0×	8.8×-0.5×	9.2×-0.3×
Per Share
Book value per share	$111.11+18.5%	$93.79+17.1%	$80.07+15.5%	$69.33+8.3%	$64.02+5.5%
Valuation
Market capitalization	$3.17T+2.6%	$3.09T+9.5%	$2.82T-3.9%	$2.93T-3.8%	$3.05T+1.4%
Price / earnings	166.9×-34.3×	201.1×-19.0×	220.1×-58.2×	278.3×-60.5×	338.8×-47.4×
Price / sales	50.8×-3.8×	54.5×-0.7×	55.2×-8.0×	63.2×-7.8×	71×-4.4×
Price / book	129.6×-20.7×	150.3×-12.4×	162.7×-27.3×	190×-21.9×	211.9×-7.7×
EV / EBITDA	130.5×-24.4×	154.9×-14.3×	169.2×-40.5×	209.7×-40.1×	249.8×-29.0×
Dividend yield	2.7%0.0pp	2.7%-0.1pp	2.8%+0.2pp	2.6%+0.2pp	2.4%+0.1pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Eli Lilly.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Eli Lilly's ratios come from?: Every ratio is computed from Eli Lilly's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.